US FDA says clears new caution for Roche flu drug
Source: Reuters
WASHINGTON, Nov 13 (Reuters) - Roche AG's <ROG.VX> influenza drug Tamiflu will carry a new precaution on the label urging close monitoring of patients for abnormal behavior such as delirium or self-injury, U.S. health officials said on Monday. "The relative contribution of the drug to these events is not known," a U.S. Food and Drug Administration statement said.
| AlertNet news is provided by |  |